| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2760 | 2021 |
| Access to effective antimicrobials: a worldwide challenge R Laxminarayan, P Matsoso, S Pant, C Brower, JA Røttingen, K Klugman, ... The Lancet 387 (10014), 168-175, 2016 | 1376 | 2016 |
| Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial … AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, ... The Lancet 389 (10068), 505-518, 2017 | 1123 | 2017 |
| Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial AM Henao-Restrepo, IM Longini, M Egger, NE Dean, WJ Edmunds, ... The Lancet 386 (9996), 857-866, 2015 | 905 | 2015 |
| A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? JA Røttingen, DW Cameron, GP Garnett Sexually transmitted diseases 28 (10), 579-597, 2001 | 795 | 2001 |
| Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? JA Røttingen, S Regmi, M Eide, AJ Young, RF Viergever, C Årdal, ... The Lancet 382 (9900), 1286-1307, 2013 | 370 | 2013 |
| Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004 PL Olliaro, PJ Guerin, S Gerstl, AA Haaskjold, JA Rottingen, S Sundar The Lancet infectious diseases 5 (12), 763-774, 2005 | 298 | 2005 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 276 | 2022 |
| Quasi-experimental study designs series—paper 4: uses and value T Bärnighausen, P Tugwell, JA Røttingen, I Shemilt, P Rockers, ... Journal of clinical epidemiology 89, 21-29, 2017 | 245 | 2017 |
| Binding of Human Factor VIIa to Tissue Factor Induces Cytosolic Ca2+ Signals in J82 Cells, Transfected COS-1 Cells, Madin-Darby Canine Kidney Cells and in Human Endothelial … R John-Arne, T Enden, E Camerer, JG Iversen, H Prydz Journal of Biological Chemistry 270 (9), 4650-4660, 1995 | 245 | 1995 |
| Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene E Camerer, JA Røttingen, E Gjernes, K Larsen, AH Skartlien, JG Iversen, ... Journal of Biological Chemistry 274 (45), 32225-32233, 1999 | 238 | 1999 |
| Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study D Gouglas, TT Le, K Henderson, A Kaloudis, T Danielsen, ... The Lancet Global Health 6 (12), e1386-e1396, 2018 | 237 | 2018 |
| What level of domestic government health expenditure should we aspire to for universal health coverage? D Mcintyre, F Meheus, JA Røttingen Health Economics, Policy and Law 12 (2), 125-137, 2017 | 232 | 2017 |
| Exploring the evidence base for national and regional policy interventions to combat resistance OA Dar, R Hasan, J Schlundt, S Harbarth, G Caleo, FK Dar, J Littmann, ... The Lancet 387 (10015), 285-295, 2016 | 218 | 2016 |
| Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries M Mendelson, JA Røttingen, U Gopinathan, DH Hamer, H Wertheim, ... The Lancet 387 (10014), 188-198, 2016 | 213 | 2016 |
| Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions? T Adam, J Hsu, D De Savigny, JN Lavis, JA Røttingen, S Bennett Health policy and planning 27 (suppl_4), iv9-iv19, 2012 | 211 | 2012 |
| Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection J Sexton, G Garnett, JA Røttingen Sexually transmitted diseases 32 (6), 351-357, 2005 | 209 | 2005 |
| International cooperation to improve access to and sustain effectiveness of antimicrobials C Årdal, K Outterson, SJ Hoffman, A Ghafur, M Sharland, N Ranganathan, ... The Lancet 387 (10015), 296-307, 2016 | 190 | 2016 |
| Guidance for evidence-informed policies about health systems: linking guidance development to policy development JN Lavis, JA Røttingen, X Bosch-Capblanch, R Atun, F El-Jardali, L Gilson, ... PLoS medicine 9 (3), e1001186, 2012 | 183 | 2012 |
| Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active E Camerer, JA Røttingen, JG Iversen, H Prydz Journal of Biological Chemistry 271 (46), 29034-29042, 1996 | 177 | 1996 |
